We investigated the association of circulating OPN with persistent symptomatology and functional/imaging abnormalities in 122 previously hospitalized COVID-19 patients (>80% of whom required supplemental oxygen during hospitalization) who were followed up at an outpatient clinic for 4–84 weeks after the onset of symptoms. This evidence concerns the gene SPP1 and COVID-19.